Latest news
Probe Scientific appoints a new Chairman
20 April 2009
Probe is please to announce the appointment of David George as Chairman. probeDavid brings with him significant industry experience and has the right skills to lead Probe to profitability and exit.
David has extensive board and operational experience in the Diagnostics, Pharmaceutical, Healthcare and other science based industries and all aspects of multinational business. His core skills are global strategy creation and implementation, high level deal negotiation, sales, marketing and customer service, R & D, manufacturing, regulatory and HR across many cultures. David's career has included roles as CEO of Glucotronics, VP Clinical and Critical Care Worldwide at Chiron Diagnostics, and senior international positions in Ciba Corning Diagnostics, Boehringer Mannheim, American Monitor Corporation and Flow Laboratories. He is chairman of CellAura Anaxsys and non-executive director of AMS Advanced Medical Services and L3 Technology.